PRESS
-
13-juil.-2016 00:41:48

Defymed Receives Support from JDRF to Fight Type 1 Diabetes JDRF will contribute up to $500,000 in funds to finance preclinical studies on the MAILPAN ® bioartificial pancreas NEW YORK, July XX 2016 – Defymed, a French biotechnology company specializing in the development of bioartificial organs today announced a partnership with JDRF, the leading global organization funding type 1diabetes (T1D) research. This new investment gives Defymed the opportunity to advance its pre-clinical studies in order to demonstrate the MAILPAN ® immunoprotection properties, safety and function. This is an essential step before beginning the clinical trials on humans. " JDRF is known as the number-one worldwide public foundation fighting type 1 diabetes. We are more than honored to be working with them for the necessary pre-clinical tests before starting the MAILPAN® clinical phase ," explains Dr. Séverine Sigrist, CEO of Defymed. " More than financial support, JRDF brings to us considerable visibility within the U.S. market and also provides strategic support in regards to finding a solution to encapsulating insulin-secreting cells to derive the benefits offered by this therapy to patients suffering from type 1 diabetes." With this support, Defymed will move significantly forward with clinical trials in humans. This new project, scheduled to take up to 24 months, will be conducted simultaneously as other research and development programs currently in progress at Defymed. It will allow Defymed to test the MAILPAN® bioartificial pancreas designed for type 1 diabetics through the preclinical phase in order to: - Strengthen the results on MAILPAN ® ’s immunoprotection properties in combination with insulin-secreting cells. - Confirm collected data on the MAILPAN ®’s functionality and safety , also in combination with insulin-secreting cells. MAILPAN® , a disruptive technology for a better life Almost 25 million people around the world suffer from type 1 diabetes. MAILPAN®, an implantable bioartificial pancreas, is a serious alternative to existing treatments. This medical device is designed to restore normal and continuous insulin production in diabetic patients. Implanted in the abdomen, it takes the shape of a pouch containing insulin-secreting cells. The potential of MAILPAN® will bring numerous advantages in comparison to current treatments (e.g., no anti-rejection drugs in case of pancreatic transplants, absence of multiple insulin injections per day). The bioartificial pancreas’ underlying principle’ is to encapsulate insulin-secreting cells between membranes impermeable to the immune system, but permeable enough for oxygen, nutrients, glucose and insulin. A bioartificial pancreas must fulfill three prerequisite functions: to protect transplanted cells from the patient immune system, to protect the patient from transplanted cells, and to maximize the function of the transplanted cells. The goal of the project is to ensure the function and safety of the medical device, utilizing Defymed’s expertise in the biomaterial and cell transplant , as well as preclinical validation and non-invasive imaging technologies. This strategic step for Defymed confirms the therapeutic interest of the MAILPAN® and will generate preclinical data that is absolutely necessary to build strong regulatory documentation for the MAILPAN® , associated with insulin-secreting cells, which will be necessary to bring it to clinical trials in humans. "JDRF is excited to announce its support of Defymed as it seeks preclinical validation of its MAILPAN® device, a project which is well aligned with JDRF’s Beta Cell Replacement strategy," said Derek Rapp, JDRF president and CEO. "By funding this type of research, we firmly believe we are moving one step closer to our goal of creating a world without type 1 diabetes. Major challenges for Alsatian biotech JRDF support appears as a testament of confidence and represents an important opportunity for Defymed to make significant strides in the biotech world. It will indeed bring more visibility and awareness to French biotech on an international platform. From a strategic standpoint, this financial support will also allow Defymed to pursue its development in Europe but also to prepare its entry in its new target market, the U.S. Defymed has also become a member of the encapsulation consortium, a key JDRF initiative. Its goal is to accelerate the development of a bioartificial pancreas for individuals living with type 1 diabetes. For the complete press release, click the link below

Geoffroy THAUMIN
-
20-avr.-2016 20:35:39

For the very first time, the GEM –the export department of the French furniture industry association– is bringing together six major French furniture players at Maison & Objet Americas. A first step in the US for the GEM, this rendez-vous with French furniture will be followed by many more! The FRENCH ART OF FURNISHING Pavilion will be located booths #1312-1417. Among the exhibitors: Gautier and its extensive range of stylish and contemporary furniture, but also Maison Montaigne Paris, who represents more than 16 European brands in their Miami showroom. Visitors will also be introduced to Fermob, Sifas and Vlaemynck. Renowned internationally for their premium and luxury outdoors furniture, their designs are created with grace and manufactured to last. Last but not least, Objet de Curiosité will showcase their many wonders, from decorative shells to steampunk lights and from exotic butterflies to mysterious stones. Already successful in France, and for some of them in the US, where their craftsmanship is recognized in niche or mainstream markets, our exhibitors are excited to present their latest designs during the show. For more information about the Pavilion or our exhibitors, please read our online catalogue .

Pauline MARIE
-
07-avr.-2016 00:18:38

We look forward to greeting you for the launch of the 7th edition of the French Pavilion on Suppliers’ Day. French cosmetics ingredients manufacturers and testing companies will present their latest innovations at the show, on May 10th and 11th in Edison, NJ. BUSINESS FRANCE is proud to introduce this year’s Pavilion’s 10 exhibitors: •ALDIVIA, •AGRIMER, •BIOALTERNATIVES, •CIMAPREM, •DERMSCAN, •EOTECH, •INTERPOLYMER, •MINASOLVE, •PACIFIQUE SUD COSMETIQUE, •TOTAL FLUIDES. For more info about the Pavilion and the companies, please visit our dedicated website . To get the most up to date information, follow us on Twitter @BF_beautycare and on our Facebook!

Elodie Fayn
-
07-avr.-2016 00:05:52

Business France is pleased to introduce the fourth International Vision Expo East French Pavilion in New York, in partnership with Lunettes de France, a national umbrella of eyewear trade associations from Paris, Oyonnax and Jura. The event will take place April 15 th to 17 th 2016 at the Vision Expo East Show. The French Pavilion will showcase 17 of the finest French companies in the eyewear industry offering contemporary and timeless spectacles as well as unique accessories staging the latest trends and designs of the French expertise. We would like to invite eyewear wholesale retailers, agents and press to visit the French Pavilion booths #6234-6245 & #6135-6141. For more information on the exhibiting French brands and location, please access the catalogue here . To learn more about the 2016 International Vision Expo, go to www.visionexpoeast.com and for additional information please contact Elodie Fayn . Follow us on Twitter @BF_FashionStyle and on Pinterest to get the latest news about the event.

Isabelle Raux - Director of the Lifestyle & Healthcare department at UBIFRANCE North America and her team assists French companies in their search for potential partners, in the US, in the following sectors: - fashion, beauty, luxury and cultural industries - decoration, design, tourism, yachting - healthcare In order to help French companies have a better understanding of the Fashion, Housing, and cosmetics markets in the US, the team organizes individualized missions (market research, list of contacts, B to B meetings) as well as collective missions, such as French Pavilion or walking delegation at the major events in the industry.

The French Suppliers Portal

UBIFRANCE, the French agency for international business development, comes under the aegis of France’s Ministry for the Economy, Industry & Employment. UBIFRANCE lies at the heart of France’s public-sector export support framework.